A BP of 220/110 mmHg demands assessment, but does not by itself diagnose a hypertensive emergency. The deciding feature is acute target-organ injury. Without it, arrange sustained BP control rather than trying to normalize the reading before discharge. 2025 AHA/ACC guideline.

Case: Severe Hypertension with Bradycardia

A 65-year-old woman taking olmesartan–hydrochlorothiazide and bisoprolol 5 mg daily presents with BP 220/110 mmHg and a pulse of 40–50/min. She describes an unusual posterior head sensation, without reported headache, visual disturbance, chest pain, dyspnea, or focal deficit. ECG shows sinus bradycardia. Creatinine and CBC are reported as normal, with no proteinuria; cardiac POCUS shows preserved ejection fraction.

She missed olmesartan–hydrochlorothiazide and took bisoprolol 5 mg twice. This creates two separate decisions: assess for acute hypertensive injury, and assess the bradycardia after a dosing error. Clarify the head symptom rather than labeling her asymptomatic at triage. Preserved ejection fraction does not clear either problem.

1. Confirm the pressure and look for injury

Repeat BP after quiet rest with a correctly sized upper-arm cuff, supported back and feet, and the arm at heart level. Reassess symptoms and perfusion alongside the measurement; do not delay emergency evaluation in an unwell patient. AHA measurement guidance.

• Neurologic or visual change: confusion, seizure, focal deficit, acute visual loss, or a sudden severe headache requires syndrome-directed investigation.
• Cardiopulmonary or aortic features: chest pain, pulmonary edema, hypoxemia, abrupt severe back pain, or pulse asymmetry changes the pathway.
• Renal concern: oliguria or suspected acute kidney injury requires comparison with baseline renal function. Chronic kidney disease alone is not acute hypertensive injury.

Address pain, distress and other reversible contributors, but do not assume they explain persistent hypertension. Check missed doses, duplicate doses, recent medication changes and access to prescriptions. AHA acute-care statement.

A blanket laboratory, ECG and imaging panel is not required for every truly asymptomatic patient. Test when findings raise concern or results will change treatment or disposition. Poor follow-up can justify creatinine testing. In this case, bradycardia and a dosing error independently justify ECG review and targeted renal/electrolyte assessment. The ACEP screening recommendation dates from 2013; the 2025 policy did not reassess screening.

2. Avoid a rapid fall; make a durable treatment plan

Longstanding hypertension alters autoregulation. A sudden pressure drop can reduce brain, coronary and renal perfusion even when the final number appears normal. Without acute injury, do not give IV antihypertensives or repeated rescue doses simply to improve the monitor reading. There is no required percentage reduction or discharge BP target for this presentation. AHA/ACC guidance.

Persistent severe hypertension still needs treatment. Reconcile and safely restart missed therapy, or select a long-acting oral regimen according to renal function, electrolytes, comorbidity and monitoring access. The 2025 guideline supports timely initiation, resumption or intensification of oral therapy.

The 2025 ACEP policy gives a Level C recommendation to consider starting outpatient antihypertensive medication at ED discharge. Evidence is limited; this is an individualized decision, especially when access to ongoing care is poor. Prescribing should accompany a workable follow-up plan, not replace it.

3. Treat the medication error as its own safety problem

Bisoprolol slows sinus rate and AV conduction. Its beta-1 selectivity does not support attributing this episode to “unopposed vasoconstriction.” Establish the exact product, dose, timing, co-ingestants and baseline pulse. Avoid further rate-slowing medication while marked bradycardia is being assessed. Review serial ECGs, perfusion and vital signs; obtain poison-center or toxicology advice when exposure or monitoring needs are uncertain. Bisoprolol prescribing information.

The case describes amlodipine 5 mg orally, followed four hours later by BP 180/90 mmHg and pulse 48–52/min. Amlodipine generally does not suppress SA/AV conduction at therapeutic doses, but its effect develops gradually and peak concentrations occur at 6–12 hours. Do not stack doses to chase an early reading. Amlodipine prescribing information.

A falling BP is not clearance for persistent bradycardia. Observation and disposition depend on the exposure timeline, symptoms, conduction, perfusion and clinical course. Four hours is not a universal safe-discharge rule. Nitrates have no role solely for an asymptomatic BP number; an actual ACS or pulmonary-edema indication requires a separate assessment.

4. Discharge with a plan the patient can use

• Write exactly which drugs to take, hold or restart, and when. Use teach-back after a dosing error.
• Arrange prompt outpatient review with a named service and an achievable appointment. Set renal/electrolyte checks when the chosen medication requires them. If access is unreliable, resolve that barrier before relying on discharge instructions alone.
• Provide a home BP recording plan and clear return precautions for new chest pain, breathlessness, neurologic or visual symptoms, fainting, or worsening dizziness.

ACEP recommends outpatient follow-up but does not establish one evidence-based interval for every patient. Timing should reflect persistent BP elevation, medication changes, symptoms and access to care. ACEP 2025 policy.

Exceptions: use the condition-specific pathway

Pregnancy and postpartum severe hypertension require urgent obstetric assessment and treatment; do not apply the nonpregnant asymptomatic pathway. ACOG guidance. Acute stroke and aortic syndromes also have distinct targets and timing. In ischemic stroke, targets depend on reperfusion treatment; the 2026 AHA/ASA guideline warns against intensive lowering after reperfusion. A generic rapid-lowering formula is unsafe across these conditions.

Bottom line: confirm the measurement, look for acute injury, avoid reflex rapid lowering, address the medication error, and secure sustained treatment and follow-up.